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Abstract
Nipah virus (NiV) is a paramyxovirus that infects host cells through the coordinated efforts
of two envelope glycoproteins. The G glycoprotein attaches to cell receptors, triggering the
fusion (F) glycoprotein to execute membrane fusion. Here we report the first crystal struc-
ture of the pre-fusion form of the NiV-F glycoprotein ectodomain. Interestingly this structure
also revealed a hexamer-of-trimers encircling a central axis. Electron tomography of Nipah
virus-like particles supported the hexameric pre-fusion model, and biochemical analyses
supported the hexamer-of-trimers F assembly in solution. Importantly, structure-assisted
site-directed mutagenesis of the interfaces between F trimers highlighted the functional rel-
evance of the hexameric assembly. Shown here, in both cell-cell fusion and virus-cell fusion
systems, our results suggested that this hexamer-of-trimers assembly was important during
fusion pore formation. We propose that this assembly would stabilize the pre-fusion F con-
formation prior to cell attachment and facilitate the coordinated transition to a post-fusion
conformation of all six F trimers upon triggering of a single trimer. Together, our data reveal
a novel and functional pre-fusion architecture of a paramyxoviral fusion glycoprotein.
PLOS Pathogens | DOI:10.1371/journal.ppat.1005322 December 8, 2015 1 / 17
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Author Summary
Paramyxoviruses infect host cells through the coordinated functions of two envelope gly-
coproteins. The G glycoprotein attaches to cell receptors triggering the fusion (F) glyco-
protein to execute membrane fusion. The crystal structure of the NiV-F protein has not
been reported. Additionally, many molecular details of the virus-cell fusion process remain
elusive, including how the higher-energy pre-fusion conformation state of the F glycopro-
tein is stabilized, or how many copies of the F glycoprotein are required for fusion. This
manuscript reports the pre-fusion crystal structure of NiV-F glycoprotein, and a func-
tional hexamer-of-trimers assembly, with six F trimers encircling a central axis. Multidis-
ciplinary data suggested that this assembly plays a role in the stability of the pre-fusion F
conformation prior to cell attachment and F-triggering to a post-fusion conformation.
Thus this assembly may coordinate this transition in all six F trimers upon triggering of a
single trimer during membrane fusion pore formation.
Introduction
Henipavirus, a relatively recently recognized viral genus in the family Paramyxoviridae, com-
prises likely over 20 species, including three established species: Hendra (HeV), Nipah (NiV)
and Cedar (CedPV) viruses, with HeV and NiV well-recognized as highly pathogenic agents
for both humans and animals [1–6]. Henipaviruses have two surface spike glycoproteins. The
G glycoprotein attaches to cell surface receptors, and upon receptor binding triggers the F gly-
coprotein to execute virus-host cell membrane fusion, facilitating viral entry [7–9]. The host
cell receptor proteins employed by the henipaviruses are B-class ephrin molecules [10–12].
The henipavirus F glycoprotein is a trimeric class I transmembrane glycoprotein synthesized as
a precursor F0 that undergoes post-translational cleavage by host cell cathepsin-L within the
endosomal compartment, yielding the fusogenic F1 and F2 subunits held together by a disulfide
bond [13–16]. Crystal structures of other paramyxovirus F glycoproteins in both pre-fusion
and post-fusion forms have been reported, supporting a model of the F glycoprotein undergo-
ing a transition from a metastable pre-fusion state to a more thermodynamically stable post-
fusion state upon activation [17–23]. This transition brings together the viral envelope and
host cell membrane to facilitate membrane fusion and viral entry. Additionally, the same viral
glycoproteins facilitate viral spread from infected to naïve cells by a similar cell-cell fusion
mechanism (syncytia formation). However, many of the molecular details of the membrane
fusion process remain elusive.
Paramyxovirus envelope-host cell membrane fusion likely shares common features with
other types of viral and cellular membrane fusion processes, such as influenza virus entry, and
synaptic vesicle fusion within neuronal cells. While influenza entry is mediated by viral glyco-
protein trimers, synaptic vesicle fusion is triggered by SNARE (soluble N-ethylmaleimide–sen-
sitive factor attachment glycoprotein receptor) molecules that functionally resemble the F
glycoprotein oligomers. It has been suggested that at least three hemagglutinin trimers are
required for influenza virus entry [24, 25]. It has also been demonstrated that at least three cop-
ies of SNAREpins are required for keeping the nascent fusion pore open long enough to ensure
efficient neurotransmitter release [26, 27]. However, cooperation of multiple fusion proteins (F
glycoproteins) in the paramyxovirus entry process has not yet been demonstrated. Here we
report a 3.4 Å crystal structure of the NiV-F glycoprotein in its pre-fusion form. Interestingly,
the structure reveals a hexameric pre-fusion assembly consisting of six copies of F glycoprotein
trimers encircling a central axis. Electron tomography and structure-based studies in the
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context of cell-cell fusion and virus-entry further support the functional relevance of the hex-
amer-of-trimers assembly. Our findings suggest a cooperative F glycoprotein trimer activation
model in the NiV entry process, providing insight into the viral-cell and cell-cell membrane
fusion mechanisms.
Results
Structure of the NiV-F protein trimer
The extracellular region of the NiV-F glycoprotein (residues 1–488) was expressed and purified
as described previously [28, 29]. A GCNt helical bundle motif was fused to the C-terminus of
the F glycoprotein to stabilize it in the pre-fusion conformation. After successful crystallization
and diffraction data collection, the crystal structure of this construct was determined at 3.4 Å
resolution by molecular replacement, using the PIV5 pre-fusion F glycoprotein structure (PDB
ID 2B9B) as a search model [20], and was refined to Rwork/Rfree of 23.0/24.8% (for details see
Materials and Methods).
The NiV-F trimer has a “tree-like” overall shape, with the three copies of the F glycoprotein
twined around a central axis (Axis-T) that is parallel to the C-terminal helical bundle (Fig 1).
The fusion peptide (FP), residing in the N-terminal segment (residues 110–122) of the F1 sub-
unit, is docked into a groove formed by the F1 subunit of a neighboring F molecule within the
trimer. Furthermore, the C-terminus of F2 and N-terminus of the FP fold into a β-hairpin
(S1-S2), that forms a continuous β-sheet with β-strands S3-S6 in the F1 subunit, thus securing
the position of the FP and stabilizing the pre-fusion state (Fig 1, inset). The cathepsin-L cleav-
age site (R109-L110), located on the tip of the β-hairpin S1-S2, is easily accessible for cleavage
in the F trimer due to its surface exposure and structural flexibility. The C-terminus of the
NiV-F construct (after D482) and the GCN tag are not visible in our structure, suggesting that
these regions are disordered.
The structure of the NiV-F glycoprotein most closely resembles the pre-fusion structure of
the PIV5 F [20] glycoprotein and the two can be superimposed with Rmsd of 2.5 Å between
1160 Cα atoms (Fig A in S1 Text). This similarity is in line with the 29% identity in their pri-
mary sequences. This similarity also suggests that these F glycoproteins undergo a similar pre-
to post-fusion transition. Interestingly, the β-hairpin (S1-S2) adopts a conformation similar to
that of the cleaved activated (CA)-PIV5 pre-fusion F glycoprotein [30], rather than of the
uncleaved form [20] (Fig A in S1 Text, inset). The NiV-F glycoprotein was expressed in human
(HEK293) cells, and N-linked carbohydrate moieties were modeled in the known four utilized
N-glycosylated sites [31–33] N99, N414, N465 & N485 (Fig 1).
Hexamer-of-trimers NiV-F assembly
NiV-F crystallized in the H3 space group, with two F trimers in each crystallographic asymmet-
ric unit (AU), which, together with the other four counterparts in the two neighboring AUs,
form a hexagonal arrangement of six F trimers surrounding a central axis (Fig 2). The Axis-Ts
of the six F glycoprotein trimers form alternative 45° and 135° angles to the hexagonal axis
(Axis-H). The C-terminal helix-bundles of the six trimeric F glycoproteins are all in the same
face of the hexameric assembly, with three of them pointing inwards, and the other three point-
ing outwards. Such an arrangement renders the maximum contact area between neighboring F
trimers due to their “tree-like” shape and surface glycan arrangements.
The observed hexameric assembly is generated via two distinct F-trimer/F-trimer interfaces
as indicated on Fig 2, burying approximately 1200 Å2 and 1100 Å2 surface area, respectively,
on each interacting F trimer. Interface 1 (Fig 2C, inset) is mainly between the S1-S6 β-sheet
and a hydrophobic patch on the surface of the adjacent F trimer. Intriguingly, the core of
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interface 1 is formed by insertion of the tip of β-hairpin S1-S2 into a hydrophobic cavity. Spe-
cifically, the side chain of R109 is embedded into a groove defined by residues P52, L53, Y248,
L256, F282, P283 and I284 of the adjacent F trimer. R109 is further stabilized by a hydrogen
bond between its main chain nitrogen and the hydroxyl group of Y248. The positive charge of
R109 is neutralized by the neighboring D107. Residues L108, L110 and A111, located on the tip
of β-hairpin S1-S2, together with Q393 and G398, located in β-strand S5 and S6, contribute
additional hydrophobic interactions. Interface 2 (Fig 2A, inset) is composed of two similar con-
tact regions involving multiple hydrogen bonds and van der Waals’ interactions. In each of
these regions, β-sheet S1-S6 on one F trimer interacts with the surface of the adjacent F trimer.
Fig 1. Structure the NiV-F trimer. The NiV-F trimer has a tree-like overall shape with the three copies of the F glycoprotein (colored in blue, green and violet)
twined around a central axis (Axis-T). The fusion Peptide (FP) is colored in red. The NiV-F trimer is shown viewed from side, and from the top. Glycosylation
moieties and disulfide bonds are shown as sticks. The inset shows a close-up view of the FP, which is located at the N-terminus of the F1 subunit, and docks
into a groove formed by the F2 subunit of a neighboring F molecule within the trimer. Furthermore, the C-terminus of F2 and N-terminus of FP fold into a β-
hairpin conformation, forming a continuous β-sheet (strands S1-S6) with the F1 subunit, which fixes the position of FP and stabilizes the pre-fusion state. The
N-terminal FP residue, L110, is shown as a red sphere.
doi:10.1371/journal.ppat.1005322.g001
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The tip of β-hairpin S1-S2 is not visible in the electron density at interface 2, presumably
because of its flexibility. The two interfaces in the hexameric assembly would stabilize the pre-
fusion F conformation by burying β-sheet S1-S6, and preventing separation of the F1 and F2
subunits.
Fig 2. Hexameric Assembly of NiV-F glycoprotein trimers. The six NiV-F copies are colored in blue, green, pink, yellow, grey and purple, respectively.
The C-terminal helical bundles of the NiV-F trimers are colored in red. Six NiV-F trimers assemble into a hexagonal ring around a three-fold crystallographic
symmetry axis. The hexameric assembly of NiV-F is presented in cartoon views from the top (A), bottom (B) and side (C). The inset in panel C shows a
hydrophobic patch of the hexameric interface between two neighboring NiV-F trimers (interface 1). Specifically, the cathepsin-L cleavage site-containing loop
of one F trimer inserts into a hydrophobic pocket of the adjacent F trimer. Residue R109 is embedded into a pocket defined by P52, L53, Y248, T250, L256,
F282, P283 and I284. The surrounding residues V108, A111, Q393 and G398 also contribute to the interaction. In the two interface inserts, the blue, green,
pink, and purple text marks residues in the monomers of the corresponding colors.
doi:10.1371/journal.ppat.1005322.g002
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Oligomeric hexamer-of-trimer state of NiV-F in solution and on virus-like
particles (VLPs)
We next investigated the oligomeric state of NiV-F in solution. Gel-filtration assays indicated
that at low concentrations (~1–2 mg/ml) the NiV-sF protein exists as a simple trimer in solu-
tion [28]. However, previous cryo-EM studies documented that the paramyxovirus F glycopro-
tein was densely packed in distinct patches on the virus surface [34], which represent an
enriched, high protein concentration 2-D environment. Therefore, purified soluble NiV-F was
concentrated to simulate physiological conditions and evaluated oligomer formation using a
crosslinking assay. The results are presented in Fig 3A, indicating that higher-order oligomers
of NiV-sF, including the apparent molecular weight equivalent of hexamers-of-trimers (top
arrow), are indeed formed in solution at high concentrations (~20–45 mg/ml). No oligomers
larger than hexamers-of-trimers were observed. Additionally, although the majority of oligo-
mers were not hexamers-of-trimers, but lower-order oligomers, it is likely that cross-linking is
not sensitive enough to capture every single hexamer-of-trimers.
Furthermore, examination of the cross-linked species by negative stain EM revealed distinct
oligomeric forms including hexamers-of-trimers (Fig 3B), which were the predominant oligo-
meric form (see Fig B in S1 Text). These oligomers appear somewhat non-uniform and varying
in appearance, suggesting that the presence of the lipid membrane and additional steric con-
straints along the envelope surface may be required for stabilization of the hexamer-of-trimer
architecture. To examine this hypothesis we employed electron tomography (ET) to visualize
the arrangement of NiV-F in a native membrane environment (Fig 3C). In agreement with
both the crystal structure and EM visualization of cross-linked NiV-F, the majority of F trimers
Fig 3. Formation of F hexamers-of-trimers in solution. (A) 100μg of 50 mg/mL sF cross-linked with 0.08% glutaraldehyde was subjected to 10–25%
sucrose gradient ultracentrifugation and fractionated. 10μL of each fraction was analyzed on Blue Native PAGE followed by western blotting. F oligomers
were probed by monoclonal mouse anti-F specific antibody. The bottom and top gradient fractions are indicated. Arrows indicate higher-order oligomers
formed from F trimers. (B) Hexameric sF assemblies imaged with negative stain EM of pooled fractions 1–6 from panel (A). It shows the cross-linked NiV-F
particles boxed out from raw images. The majority of NiV-F oligomers appear as hexamers-of-trimers. (C) A small density slab (7.4 nm thick) from an electron
tomogram of NiV-F decorated VLP showing the hexameric arrangement of the NiV-F spikes on the VLP. The individual NiV-F spikes are ~8–10 nm long with
a ~1–2 nm stalk, consistent with the electron microscopy studies of soluble PIV5-F in its pre-fusion state [59]. The hexameric assembly revealed in NiV-
sFGCNt crystal structure was shown next to it as reference.
doi:10.1371/journal.ppat.1005322.g003
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were observed as hexamers-of-trimers (in addition to single F trimers–see Fig B in S1 Text) on
viral-like particles (VLPs) with full-length F. Moreover, interactions between hexamers-of-tri-
mers were observed, with one trimer being part of more than one hexamer-of-trimers, some-
times resembling a soccer ball arrangement. Although one cannot exclude artifacts due to
dehydration during ET and/or heavy metal deposition during negative staining of the VLPs,
the shapes and sizes of the observed NiV-F spikes and spike assemblies are fully consistent
with the structures of the pre-fusion F trimers, the crosslinking results, and the hexamers-of-
trimers observed by X-ray crystallography.
Hexameric interface mutations affect cell-cell and viral-cell membrane
fusion
Next, to evaluate whether there is any functional relevance for the NiV-F hexamer-of-trimer
assembly, structure-based targeted mutations were designed to either destabilize (L53D and
V108D) or stabilize (R109L and Q393L) the hexameric interfaces. Residues L53, V108 and
R109 are among the key components in the formation of the hexameric interface 1 hydropho-
bic core (Fig 2C, inset); while residue Q393, located in β-sheet S5 (insets of Fig 2A and 2C), is
involved in forming both interfaces 1 and 2. L53D, for example, would abrogate the hydropho-
bic groove in interface 1, while V108D would not only decrease the local hydrophobicity, but
also create a repulsive electric force with D252, and weaken interface 1. On the other hand, the
R109L substitution would favor embedding the side chain of this residue in the hydrophobic
groove of the adjacent F trimer. Similarly, Q393L would not only enhance the hydrophobicity
of interface 1, but would also form favorable van der Waals interactions with L53 and I284 of
the adjacent F trimer in interface 2.
These four F mutants were evaluated first in a HeLa-USU/HEK293T cell-cell fusion assay
(Fig 4A and 4B). Remarkably, the mutations predicted to impair the hexameric interfaces
reduced the cell-cell fusion efficiency (P<0.01), while the mutations predicted to stabilize the
hexamer-of-trimer interfaces tended to enhance cell-cell fusion efficiency, in comparison to
wild-type (wt) NiV-F. The normalized fusion levels shown in Fig 4A already take into account
glycoprotein cell surface expression levels. Polyclonal anti-F specific antibody and conforma-
tion-specific monoclonal antibodies (mAbs 5B3, 5E5, 12B2) were used to confirm that these
mutations in the hexameric interfaces did not affect normal F processing and the overall fold-
ing and structure of the F glycoprotein (Fig 4B and 4C). Residue L53 is also a critical residue
within the epitope recognized by mAb 5B3 (Chan and Broder, manuscript in preparation), as
revealed by its defective binding to the 5B3 mAb (Fig 4C).
To confirm the importance of the hexamer-of-trimer assembly and interfaces for virus-host
cell membrane fusion, the NiV-F mutants were next tested in the context of virion entry. Spe-
cifically, a well characterized pseudotyped virus entry assay [31, 35] was used to compare the
entry efficiencies of viral particles containing either wt or mutant NiV-F over several logs of
viral input. The results (Fig 5) were fully consistent with the results derived from the cell-cell
fusion assay. It should be noted that while R109L showed the same viral entry levels as WT F,
the overall level of incorporation of R109L into VSV particles was significantly lower than WT
F levels, suggesting that this mutant indeed supports higher entry efficiency than the WT F
glycoprotein.
Discussion
A synergetic NiV-F activation and a cooperative fusion-pore opening model can be deduced
from our results as depicted in Fig 6. Significant conformational changes and movement of the
FP region are thought to occur during F protein transition from pre-fusion to post-fusion
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states. The β-sheet S1-S6 structure (insets of Figs 1, 2A, 2C and S1 Text) partially sequesters the
FP, therefore stabilizing the pre-fusion F conformation. Disruption of this β-sheet would free
the FP and facilitate the energetically favorable transition to a post-fusion conformation, pro-
viding an efficient way to trigger F protein activation. In the hexameric F assembly, β-sheet
S1-S6 is buried in the hexameric interface and, therefore, the pre-fusion F conformation is sta-
bilized. On the other hand, disturbance or dissociation of the hexameric assembly would apply
mechanical force on the interface-forming β-sheet S1-S6 triggering F protein activation. The
residues on the tip of β-hairpin S1-S2, as well as the hexameric interface-forming residues on
β-strands S3-S6, are therefore crucial for the regulation of NiV-F activation and fusion effi-
ciency in this model, and we refer to these sites as “priming sites”. Each F-trimer contains 3
priming sites–two of which are buried within the hexamer interfaces, while the third is avail-
able for interaction with (and priming by) the NiV-G/ephrin complex (Fig 6).
Consistent with this model, several of the residues in this “priming site” have been previ-
ously shown to mediate the viral fusion-attachment (F-G) protein interactions in the PIV5
virus [36]. Upon viral attachment, the ephrin-mediated re-arrangements of NiV-G would exert
a triggering disturbance at an exposed “priming site” (presumably via direct G-F priming-site
interactions). This triggers the F glycoprotein trimer to undergo a conformational change from
a pre-fusion to a post-fusion configuration. Upon activation by a NiV-G/ephrin complex, the
Fig 4. Cell-cell fusion andmAb binding activities of NiV-F mutants. Four mutants of NiV-F within the
trimer-trimer interface were tested for their ability to promote cell-cell fusion when co-expressed with NiV-G in
a β-Gal reporter cell-cell fusion assay using HEK293T cells as the target population. (A) The data shown are
the mean percentage of WT fusion levels measured for each mutant calculated from four separate
experiments. The data was normalized for cell surface expression of WT F measured by flow cytometry,
using a F-specific mAb that recognizes total F surface expression. The bars represent the range frommultiple
experiments. WT: wild type F. Statistical analysis probes activity deviation relative to WT. *: p<0.01; **:
p<0.001; p = 0.3668 for R109L; p = 0.1488 for Q393L. (B) Expression of NiV-F mutants and NiV-G in HeLa
USU cells from (A). Equal amount of remaining cells from fusion were lysed and clarified by centrifugation
followed by immunoprecipitation by polyclonal rabbit anti F and G serum and protein G Sepharose. The
precipitated products were analyzed on SDS PAGE followed by western blotting. F and G were probed by
monoclonal mouse anti F (upper panel) and G (lower panel) specific antibody. (C) Cleared lysates of NiV-F
mutants expressed in 293T cells were immunoprecipitated with 3 different competition groups of neutralizing
anti F mAb as indicated. All 3 mAbs efficiently immunoprecipitatedWT F. The precipitated complexes were
analyzed on SDS-PAGE followed by western blotting and F was probed using polyclonal rabbit anti-F
antisera.
doi:10.1371/journal.ppat.1005322.g004
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contacted F trimer would not only destabilize the pre-fusion state in its interacting neighbors,
but could also directly facilitate an alteration in their “priming sites,” triggering a conformation
switch in the rest of the hexamer-of-trimer assembly. Thus, a single ephrin/NiV-G/F trimer
interaction would result in the synergetic switch from a pre-fusion to a post-fusion conforma-
tion in all six F trimers within the assembly (Fig 6). The resulting eighteen copies of the post-
fusion F protein (forming eighteen six-helix bundles) is more likely to pull the two membranes
together than triggering of a single F trimer alone. The combination of biochemical and micro-
scopical data (Fig 3), and functional cell-cell fusion (Fig 4), and viral entry (Fig 5) data, is con-
sistent with this model.
The necessity for multiple fusion glycoproteins acting together to affect membrane fusion
has been most clearly demonstrated for the SNAREpins (composed of v- and t- SNAREs) dur-
ing the neurotransmitter cargo-releasing fusion process in synapses [26, 27]. Several lines of
evidence suggest similar requirements for various enveloped viruses, including influenza, HIV,
baculovirus, Semliki Forest virus, and vesicular stomatitis virus [24, 25, 37–43]. Multiple copies
of fusion glycoproteins around the entry site would provide a radial force around the newly
fused lipid bilayers that cooperatively stabilizes and opens up the nascent fusion pore, allowing
Fig 5. Viral entry is affected by mutations in the hexameric interface. (A) Relative entry levels of NiV/
VSV-rluc virions containing wt NiV-G and wt NiV-F (solid black line) or mutant L53D, V108D, R109L or Q393L
NiV-F (dotted red line). Vector alone (pcDNA3)/VSV is shown as a dotted gray line. RLU for lysates of
infected Vero cells were quantified 18–24 h post infection and plotted against the number of viral genomes/ml
over 3 logs of viral input. Data shown are averages ± SEM from at least three independent experiments
(n = 3). (B) Representative Western blot analysis of NiV/VSV-rluc virions shown under Fig 5A. 4x108 NiV/
VSV pseudotyped virions (genome copies) were separated by denaturing 10% SDS–PAGE and probed
against NiV-G (rabbit anti-HA, Bethyl) and NiV-F (mouse anti-AU1, Covance).
doi:10.1371/journal.ppat.1005322.g005
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efficient virus entry into the host cell. The core fusion machinery for NiV entry consists of a
single glycoprotein, F, which localizes at the viral envelope prior to viral entry. Furthermore,
the attachment and the fusion process are exerted by two separate glycoproteins (G and F,
respectively). Therefore, the oligomeric assemblies of F glycoproteins and their synergetic acti-
vation triggered by the ephrin/G complexes provide an efficient way to ensure the simulta-
neous availability of multiple NiV-F helix bundles at the contact zone where G glycoproteins
are attracted to the host cell-surface ephrins.
Noteworthy, the cathepsin cleavage site (R109/L110) is accessible in the trimer (Fig 1), but
fairly buried in interface 1 of the hexameric assembly (Fig 2). So how/when does the cathepsin
cleavage occur? F glycoproteins can exist as trimers on the cell surface and on virions in both
cleaved and uncleaved forms [44, 45]. Following cathepsin-L cleavage F could shift primarily
to the hexamer-of-trimer assembly. Alternatively however, cleavage of F may occur even in the
hexamer-of-trimer structural assembly, as the cleavage site is not completely blocked in all hex-
americ interfaces. In addition, it is likely that R109 and L110 are not the only determinants of F
cleavage, as at least F mutant R109 is still cleaved (Figs 4C and 5B). It is clear that F trimers traf-
fic to the plasma membrane before cleavage and then are cycled back into the cell where cleav-
age occurs, and then recycled back to the cell surface, and both cleaved and uncleaved F exist
inside and on the surface of expressing cells [14, 35, 46]. It is also possible that both cleaved
Fig 6. Schematic representation of the proposed NiV-F activationmodel.Upon viral attachment, the ephrin receptor-mediated re-arrangements of
NiV-G exert a triggering disturbance at an exposed “priming site” (presumably via direct G-F priming-site interactions) that is sufficient to activate one F
glycoprotein trimer and trigger its transition from a pre-fusion to a post-fusion conformation. The transformation of a single F trimer within the hexameric
assembly would disrupt its interactions with both of its neighbors, unlocking their “priming sites” and facilitating their pre-to-post fusion transitions. Thus a
single ephrin/NiV-G/F trimer interaction would result in the synergetic switch from a pre-fusion to a post-fusion conformation in all six F trimers within the
hexameric assembly. The resulting eighteen copies of the six-helical post-fusion F bundle would form a stable fusion pore allowing virus entry into the host
cell.
doi:10.1371/journal.ppat.1005322.g006
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and uncleaved F monomers co-exist within a trimer and/or within the hexamer-of-trimer
assembly. Furthermore, it is also possible that a hexameric structure is not static and that tri-
mers may form and disassemble from higher order oligomeric forms allowing for cleavage to
occur.
Further experimentation is required to unequivocally establish this mechanistic model.
Although evidence in this study suggest that a hexamer-of-trimers assembly is a functional
form for the F protein, it remains to be determined whether this is the primary assembly form
of F in the presence of G. Furthermore, studies of other paramyxoviruses indicate that the
transmembrane regions of the F proteins are critical to stabilize the pre-fusion structure, often
requiring a stabilizing GCN4 domain [20, 30]. Consistently, our pre-fusion structure and hex-
amer-of-trimer assembly observed for NiV-F was a result of addition of a GCN4t domain to
replace the F transmembrane and cytoplasmic tail regions. It remains to be determined
whether the same structural features will be observed for the full-length F proteins embedded
in a cellular membrane. Technical challenges prevent such studies from being performed
under current available technologies. However, the prevalence of F hexamers-of-trimers in
VLPs containing full-length F without a GCN4t domain, in combination with our functional
studies, support our current F pre-fusion and hexamer-of-trimers structural results. In addi-
tion, it remains to be determined whether this relatively simple mechanistic model applies to
other enveloped viruses. It should be noted that various oligomeric viral fusion-protein assem-
blies, e.g. containing 3–10 copies, could serve the same purpose in other viral systems by poten-
tially stabilizing the pre-fusion conformation and by facilitating a cooperative transition to the
post-fusion conformation in all glycoproteins within the assembly upon transition of a single
fusion protein.
Materials and Methods
Construct design and glycoprotein expression
The construction, expression and purification of the GCNt stabilized pre-fusion soluble version
of the NiV-F glycoprotein (NiV-sFGCNt) had been detailed previously [28, 29]. Briefly, The
predicted transmembrane (TM) anchor domain (residues 488–510) and the C-terminal cyto-
plasmic tail (CT) domain (residues 511–546) of the NiV- F were replaced by the GCNt motif
(MKQIEDKIEEILSKIYHIENEIARIKKLIGE) [47] in heptad phase followed by a Factor Xa
protease cleavage site (IEGR) and the S-peptide tag. A 293T stable cell line expressing the NiV-
sFGCNt was generated. Preparation of the sF glycoprotein from 293T stable cell lines was car-
ried out using serum-free culture conditions and employing a combination of S-protein aga-
rose (EMD Biosciences) affinity column and size exclusion chromatography using a HiLoad
16/60 Superdex 200 preparative grade gel filtration column (GE Healthcare) steps to isolate
pure NiV-sFGCNt trimer.
Crystallization and structure determination
Crystals of NiV-sFGCNt formed after two weeks in 2μl hanging drops by vapor diffusion
against reservoir solution (in a 1:1 protein-to-reservoir-solution ratio) containing 0.1 M
HEPES pH 7.3, 1% Jeffamine ED-2001 and 1.2 M SodiumMalonate. For cryo-protection, crys-
tals were soaked step-wise in reservoir solution starting from 5% up to 25% glycerol and were
flash-frozen in liquid nitrogen. Diffraction data were collected at beamline NE-CAT ID-24 of
the Advanced Photon Source at Argonne National Laboratory and processed with HKL2000
program package[48]. The structure was determined by molecular replacement with PDB ID
2B9B (PIV5 pre-fusion F protein) as the searching model and MOLREP program in CCP4
Suite [49]. The structure was refined carefully with grouped B-factor refinement (two B-factors
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per residue), and non-crystallographic symmetry (NCS) restrains in CNS1.2 [50]. NCS
restrains were applied to the six chains of NiV-F in one asymmetric unit. The electron density
maps for model building were improved by B-factor sharpening with a value of -70 Å2. All
model building was performed in Coot [51]. The final structure model was checked by the pro-
gram PROCHECK [52]. Statistics of data collection and refinement are listed in Table A in S1
Text. Noteworthy, all conserved Cys residues aligned between the NiV and PIV5 F structures.
Crosslinking assay and Sucrose gradient PAGE
Purified NiV-sFGCNt trimer was concentrated to 50 mg/mL using the Corning Spin-X UF
500μL Centrifugal Concentrator (Corning Inc). Glutaraldehyde was added to the concentrated
material to various final concentrations ranging from 0.005% to 0.1% yielding protein concen-
trations between 40–45 mg/mL. 5μg of cross-linked products were analyzed on Blue Native
PAGE (Invitrogen) with Coomassie staining. To separate different oligomeric species of cross
linked NiV-sFGCNt trimer, 100μg of the 50 mg/mL sF was cross-linked with 0.08% gluteralde-
hyde yielding a final protein concentration of 42 mg/mL and the cross linked material was then
subjected to 10–25% sucrose gradient ultracentrifugation and fractionated. To obtain the gradi-
ent, 6 ml of 10% sucrose was underlaid with 6 ml of 25% sucrose in a polyallomer 14- by
95-mm tube. A linear sucrose gradient was generated using the Biocomp Gradient Master (Bio-
comp, Frederickton, NB, Canada) at an angle of 81.5° for 2 min 19 seconds at a speed of 14k
rpm. The cross linked material was then overlaid on top of the gradient. The gradient was cen-
trifuged at 40,000 rpm for 20 h at 4°C using an SW40 rotor (Beckman Coulter, Inc.). Fractions
of ~200 μl each were collected from the bottom to the top of the gradient using a Beckman frac-
tion recovery system and automated fraction collector. To analyze the fractions, 10 μl of each
collected fraction was resolved on 3–12% BN-PAGE (Invitrogen) followed by western blotting.
F oligomers were probed by monoclonal mouse anti-F specific antibody. Fractions with higher
oligomers were pooled, desalted, concentrated and analyzed on Blue Native PAGE using Coo-
massie staining.
Negative stain electron microscopy
Samples were prepared using conventional negative staining protocols [53]. Briefly, 3 μL of
sample was pipetted onto a glow-discharged carbon-coated grid and stained with 1% (w/v) ura-
nyl formate. Imaging was performed at room temperature with a Morgagni 268(D) transmis-
sion electron microscope (FEI Company) at 100kV at a magnification of 30,416x.
Electron Tomography of VLPs
NiV-F VLPs were produced by expressing NiV-F on 293T cells and then collecting, clearing,
and purifying the cell supernatants through 20% sucrose, as previously established [54]. It has
also been established that NiV-F can autonomously assemble and produce budding of NiV-F
VLPs [55]. 3 μl VLP sample was applied on carbon covered copper grids. After one minute the
fluid was absorbed with filter paper and 3 μL urinyl acetate (UA) (2.5%) was applied for 40 sec-
onds. Excess UA was absorbed and the grid was left to dry for 2 minutes before being trans-
ferred to a Gatan-626 specimen holder. A Tecnai F20 transmission electron microscope
(200kV) (FEI Company, OR) equipped with a field mission gun (FEG), computer-controlled
compustage, a TIETZ F415MP 16 megapixel CCD camera was used to obtain a total of 141
tomographic images at tilts from -70 to +70 degrees. Tilt series were collected at 29,000x mag-
nification with an applied defocus of -3 μmwith FEI’s Batchtomography package. Tilt series
alignment and tomographic reconstruction were performed by IMOD [56].
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Cell-cell fusion assays
Fusion between NiV F and G glycoprotein-expressing effector cells and permissive target cells
was measured by a β-Galactosidase (β-Gal) assay that was previously described [57]. Briefly,
plasmids encoding WT NiV F or each mutant of F and NiV G at a 1:1 ratio or control/mock
transfection were transfected into HeLa-USU effector cells. The transfected cells were then
infected with vaccinia virus-encoding T7 RNA polymerase the following day. HEK293T cells
served as receptor-positive target cells were also infected with the E. coli Lac Z-encoding
reporter vaccinia virus. Cells were infected at an MOI of 10 and incubated at 31°C overnight.
Cell-cell fusion reactions were conducted by incubating the target and effector cell mixtures at
a ratio of 1:1 in 96-well plates at 37°C. Cytosine arabinoside (40μg/ml) was added to the fusion
reaction mixture to reduce nonspecific β-Gal production. Nonidet P-40 was added to 0.5%
final concentration at 2.5 hrs, and aliquots of the lysates were assayed for β-Gal at room tem-
perature with the substrate chlorophenol red–D-galactopyranoside (Roche). Assays were per-
formed in triplicate, and fusion results were calculated and expressed as rates of β-Gal activity
(change in optical density at 570 nm per minute x 1,000) in VersaMAXmicroplate reader
(Molecular Devices, Sunyvale, CA). Equal amount of leftover envelope glycoprotein expressing
effector cells from each fusion reaction was used for evaluation of total F and G expression by
immunoprecipitation and cell surface F expression by flow cytometry. For immunoprecipita-
tion, cells were lysed and clarified by centrifugation. The lysates were then subjected to rabbit
polyclonal anti-F or -G specific antisera and protein G Sepharose precipitation followed by
SDS PAGE and western blot analysis. The blots were probed with F or G specific murine
mAbs. For flow cytometry, the envelope expressing cells were washed once with PBS and then
incubated with pre-fusion specific F mAb followed by incubation with fluorescein isothiocya-
nate (FITC)-conjugated polyclonal anti mouse Ab (Cell Signaling Technology, Inc., Danvers,
MA). All incubations were in PBS with 3% goat serum and on ice for 1 h. Samples were washed
three times with cold PBS between incubations and before being fixed in 1.6% paraformalde-
hyde and then analyzed on a Beckman Coulter Epics XL flow cytometer. The individual cell
fusion reactions mediated by each mutant were converted to percentages of WT fusion activity
and normalized with cell surface expression of WT F and each F mutants.
Pseudotyped virus entry assay
VSV-rLuc pseudotype viruses, harboring NiV-F and–G on their surface, were produced as pre-
viously described [31]. All NiV-F (C-terminal AU1-tag) and–G (C-terminal HA-tag) con-
structs, utilized for the production of the pseudotyped viruses, were cloned in the pcDNA3.1
vector. Viral copy numbers were quantified by real-time PCR [31] and 10-fold serial dilutions
of each viral prep were tested on Vero cells for viral entry using a renilla luciferase detection
system (Pierce) [58]. Relative light units (RLUs) were plotted against the viral genome copy
number per milliliter and analyzed by linear regression using GraphPad Prism as previously
described [58].
Illustrations
All molecular representations were produced with PyMOL (Delano Scientific LLC). Figures
were prepared using Adobe Illustrator, Adobe Photoshop.
Supporting Information
S1 Text. (Fig A) Comparison of the NiV-F trimer structure with these of the cleavage-acti-
vated (CA)-PIV5-F, and non-activated PIV5-F. (Fig B) Representative raw NiV-F EM and
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